Corcept Therapeutics Incorporated Stock Price on December 19, 2024
| CORT Stock | USD 52.42 2.72 4.93% |
Below is the normalized historical share price chart for Corcept Therapeutics Incorporated extending back to April 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corcept Therapeutics stands at 52.42, as last reported on the 19th of December, with the highest price reaching 55.99 and the lowest price hitting 52.02 during the day.
If you're considering investing in Corcept Stock, it is important to understand the factors that can impact its price. Corcept Therapeutics appears to be very steady, given 3 months investment horizon. Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Corcept Therapeutics Incorporated, which you can use to evaluate the volatility of the firm. Please makes use of Corcept Therapeutics' Risk Adjusted Performance of 0.1331, mean deviation of 2.31, and Downside Deviation of 2.54 to double-check if our risk estimates are consistent with your expectations.
At this time, Corcept Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 652.6 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 98.3 M in 2024. . At this time, Corcept Therapeutics' Price Earnings Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 6.97 in 2024, whereas Price To Sales Ratio is likely to drop 6.62 in 2024. Corcept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of April 2004 | 200 Day MA 36.6136 | 50 Day MA 53.2074 | Beta 0.455 |
Corcept |
Sharpe Ratio = 0.1346
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CORT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.84 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Corcept Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corcept Therapeutics by adding it to a well-diversified portfolio.
Price Book 9.0435 | Enterprise Value Ebitda 37.3947 | Price Sales 8.738 | Shares Float 85.7 M | Wall Street Target Price 74.9 |
Related Headline
AnaptysBio Headline on 18th of December 2024
GILD and GSK are in the spotlight in the biotech sector with quite a few regulatory and pipeline updates.
Corcept Therapeutics Valuation on December 19, 2024
It is possible to determine the worth of Corcept Therapeutics on a given historical date. On December 19, 2024 Corcept was worth 54.95 at the beginning of the trading date compared to the closed value of 52.42. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Corcept Therapeutics stock. Still, in general, we apply an absolute valuation method to find Corcept Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corcept Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Corcept Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 55.26 | 56.13 | 54.14 | 55.14 | 617,774 | |
12/18/2024 | 54.95 | 55.99 | 52.02 | 52.42 | 797,657 |
| Backtest Corcept Therapeutics | | | Corcept Therapeutics History | | | Corcept Therapeutics Valuation | Previous |
Corcept Therapeutics Trading Date Momentum on December 19, 2024
| On December 18 2024 Corcept Therapeutics Incorporated was traded for 52.42 at the closing time. The top price for the day was 55.99 and the lowest listed price was 52.02 . The trading volume for the day was 797.7 K. The trading history from December 18, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.83% . |
Corcept Therapeutics Fundamentals Correlations and Trends
By evaluating Corcept Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Corcept financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Corcept Therapeutics Stock history
Corcept Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corcept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corcept Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corcept Therapeutics stock prices may prove useful in developing a viable investing in Corcept Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 111.7 M | 83.1 M | |
| Net Income Applicable To Common Shares | 116.5 M | 122.3 M |
Corcept Therapeutics Quarterly Net Working Capital |
|
Corcept Therapeutics Stock Technical Analysis
Corcept Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Corcept Therapeutics Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Corcept Therapeutics Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Corcept Therapeutics December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Corcept Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corcept Therapeutics shares will generate the highest return on investment. By undertsting and applying Corcept Therapeutics stock market strength indicators, traders can identify Corcept Therapeutics Incorporated entry and exit signals to maximize returns
Corcept Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corcept Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Corcept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corcept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1331 | |||
| Jensen Alpha | 0.4296 | |||
| Total Risk Alpha | 0.383 | |||
| Sortino Ratio | 0.1712 | |||
| Treynor Ratio | 0.3639 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.